BofA analyst Tazeen Ahmad upgraded PTC Therapeutics (PTCT) to Neutral from Underperform with a price target of $55, up from $41. The firm cites the FDA having fast tracked potential approval for v ...

Scotiabank analyst Louise Chen initiated coverage of PTC Therapeutics (PTCT) with a Sector Perform rating and $55 price target Scotiabank believes the stock is fairly valued at current levels ...

India's ONGC unit buys clean energy firm PTC Energy for $106 mln Indian oil explorer Oil and Natural Gas Corp said on Tuesday its unit acquired clean energy firm PTC Energy for 9.25 billion Indian ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Microsoft, alongside partners like PTC, believe we are at the pivotal moment where digital ... like customer relationship management (CRM), product lifecycle management (PLM), enterprise resource ...

After hours: March 11 at 6:36:09 PM EDT Loading Chart for PTC ...

The cybersecurity agency CISA on Monday added an Oracle Agile Product Lifecycle Management (PLM) software flaw to its Known Exploited Vulnerabilities (KEV) catalog. The vulnerability, tracked as ...

After hours: March 13 at 7:59:57 PM EDT Loading Chart for ICON ...